BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14556263)

  • 1. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library.
    Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y
    J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
    Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
    Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
    Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
    EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
    Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
    Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
    Zhou YH; Moriyama M; Esumi M
    Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
    Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
    Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
    Shang D; Zhai W; Allain JP
    Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
    Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
    Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus.
    Wang YS; Fan HJ; Li Y; Shi ZL; Pan Y; Lu CP
    Vaccine; 2007 May; 25(22):4447-55. PubMed ID: 17445956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Reactivity of Synthetic Peptides Originated from Hypervariable Region 1 of Hepatitis C Synthetic Consensuses with Egyptian Sera Infected with Hepatitis C Virus Type 4.
    Abdel-Fattah M; Charmy R; Tawfik AR
    Intervirology; 2015; 58(4):232-41. PubMed ID: 26330263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.
    Shimizu YK; Igarashi H; Kiyohara T; Cabezon T; Farci P; Purcell RH; Yoshikura H
    Virology; 1996 Sep; 223(2):409-12. PubMed ID: 8806581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mimotope of Leptospira from phage-displayed random peptide library is reactive with both monoclonal antibodies and patients' sera.
    Tungtrakanpoung R; Pitaksajjakul P; Na-Ngarm N; Chaicumpa W; Ekpo P; Saengjaruk P; Froman G; Ramasoota P
    Vet Microbiol; 2006 Jun; 115(1-3):54-63. PubMed ID: 16581206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.
    Del Porto P; Puntoriero G; Scottà C; Nicosia A; Piccolella E
    Virology; 2000 Apr; 269(2):313-24. PubMed ID: 10753710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
    Zhou YH; Sugitani M; Esumi M
    Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the phage display technology for the identification of a hepatitis C virus NS4A epitope recognized early in the course of the disease.
    Ferrieu-Weisbuch C; Bettsworth F; Becquart L; Paranhos-Baccala G; Michel S; Arnaud M; Jolivet-Reynaud C
    J Virol Methods; 2006 Feb; 131(2):175-83. PubMed ID: 16183141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic complexity and serum reactivity of HVR1 quasispecies of hepatitis C virus in patients with cirrhosis.
    Fan X; Di Bisceglie AM
    Am J Gastroenterol; 2002 Jun; 97(6):1489-95. PubMed ID: 12094871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
    Nemchinov LG; Liang TJ; Rifaat MM; Mazyad HM; Hadidi A; Keith JM
    Arch Virol; 2000; 145(12):2557-73. PubMed ID: 11205105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.